Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
617 articles
A landmark review maps how computational heart models can decode diabetic cardiomyopathy and predict responses to SGLT2i and GLP-1 drugs.
Researchers defend their findings on screening-detected atrial fibrillation and cardiovascular outcomes in younger adults.
Columbia cardiologists describe an unusual mechanical cause of congestive heart failure where impaired ventricular filling is the central culprit.
A novel TRPM7-zinc pyroptosis pathway may explain why heart tissue dies during ischemia-reperfusion injury.
Yale researchers map the neurocardiac axis, revealing how autonomic dysfunction drives major cardiovascular diseases and pointing to new neural therapies.
New research reveals how gut barrier breakdown activates cardiac JNK2, driving age-related atrial fibrillation through inflammation.
A Cochrane review of 4 RCTs finds no reliable evidence that adding endovascular stenting to medical therapy prevents stroke or death in vertebral artery stenosis.
A multiregistry study of 587 pediatric HCM patients finds massive LVH dramatically raises arrhythmia and mortality risk, especially in young children.
A new mechanism linking LMNA mutations to cardiac arrhythmias and dysfunction in Emery-Dreifuss muscular dystrophy points to promising drug targets.
A new molecular target — the E3 ubiquitin ligase Hrd1 — may prevent heart damage after blood flow is restored following a heart attack.
New paradigm targets inflammation and neurohormonal dysfunction to achieve heart failure remission rather than just symptom management.
Leading cardiologists respond to recent findings on sudden cardiac arrest prevention in athletic populations.
